# FDA Inspection 1181516 - Valdepharm - January 21, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/valdepharm/98fa0921-e3ae-4122-8843-0071adc9637d/
Source feed: FDA_Inspections

> FDA Inspection 1181516 for Valdepharm on January 21, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181516
- Company Name: Valdepharm
- Inspection Date: 2022-01-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 923783 - 2015-04-27](https://www.globalkeysolutions.net/api/records/fda_inspections/valdepharm/3cf5a26e-09f8-4f22-a9ce-819f776d0db5/)
- [FDA Inspection 923783 - 2015-04-27](https://www.globalkeysolutions.net/api/records/fda_inspections/valdepharm/501e7267-cdf4-4880-b310-2cdf5fe864ce/)
- [FDA Inspection 891979 - 2014-07-10](https://www.globalkeysolutions.net/api/records/fda_inspections/valdepharm/992ba72d-73ad-4f49-add8-e0c36777b182/)
- [FDA Inspection 788262 - 2012-05-25](https://www.globalkeysolutions.net/api/records/fda_inspections/valdepharm/4d032987-be41-430e-b9e9-63b67de73e63/)

Company: https://www.globalkeysolutions.net/companies/valdepharm/9a1bab54-2984-4dec-8384-e3aaa423bda7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c